SureTrader Advertisement SureTrader
Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 284
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
Top Equities Stories of the Day
A group including private-equity firm Apollo Global Management LLC boosted its bid for Apollo Education Group Inc. in an effort to salvage...
FCC to Sell Maximum Amount in TV Airwave Auction
Valeant Default Fears 'Cured' -- WSJ
Hulu Bets on Cable-Style Web TV
Exxon Swoons, but Investors Cheer -- WSJ
CBOE Reports Higher Earnings, Revenue Thanks to Trading Shift
Amazon Kindle Oasis Video Review: Up Close With the Luxury E-Reader
Twitter Looks to Video to Increase Advertising Sales
Abbott to Acquire St. Jude -- WSJ
Ford Profit Doubles as New Models Soar -- WSJ
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 671252 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist